Michael Schrader | Co-Founder And Chief Executive Officer
Vaxess Technologies, Inc

Michael Schrader, Co-Founder And Chief Executive Officer, Vaxess Technologies, Inc

Michael Schrader is the founding CEO of Vaxess Technologies, a Gates Foundation and venture-backed company developing next-generation vaccines on the MIMIX sustained-release microneedle platform. MIMIX combines high temperature stability, ease of administration, and enhanced immunogenicity through “infection mimicry” to create more effective vaccines that are easily delivered around the world. Prior to founding Vaxess, Michael spent time at Google, Toyota, and Honda R&D where he helped bring a wide range of products to market and earned fifteen patents for innovative new designs. Michael received his B.S. in Mechanical Engineering from Purdue University and his M.B.A. from Harvard Business School.


April 17 Day 3 - 10 Co-conferences & Plenary @ 09:55

MIMIX Flu, is a broadly protective, shelf-stable, self-administered influenza vaccine

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071